Literature DB >> 15060489

Implant-tissue supported, magnet-retained mandibular overdenture for an edentulous patient with Parkinson's disease: a clinical report.

Frederick C S Chu1, Fei L Deng, Adam S C Siu, Tak W Chow.   

Abstract

Degenerative neurologic disorders such as Parkinson's disease are becoming more prevalent as life expectancy is improved. Although the use of an implant-supported overdenture is an acceptable treatment modality, the clinician should recognize the indications and maintenance requirements of different attachment systems for individual patients. The use of a magnetic attachment system in an implant-supported mandibular overdenture for an edentulous patient with Parkinson's disease is presented.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15060489     DOI: 10.1016/j.prosdent.2003.12.014

Source DB:  PubMed          Journal:  J Prosthet Dent        ISSN: 0022-3913            Impact factor:   3.426


  5 in total

Review 1.  Oral health and implant therapy in Parkinson's patients: review.

Authors:  P Bollero; R Franco; F Cecchetti; M Miranda; A Barlattani; A Dolci; L Ottria
Journal:  Oral Implantol (Rome)       Date:  2017-09-27

2.  Increased periodontal pathology in Parkinson's disease.

Authors:  Johannes Schwarz; Engelbert Heimhilger; Alexander Storch
Journal:  J Neurol       Date:  2006-03-06       Impact factor: 4.849

3.  Oral rehabilitation of a Parkinson's patient: A case report.

Authors:  Yashpal Singh; Monika Saini; Neha Garg
Journal:  World J Clin Cases       Date:  2013-04-16       Impact factor: 1.337

4.  Clinical strategies for complete denture rehabilitation in a patient with Parkinson disease and reduced neuromuscular control.

Authors:  Satheesh B Haralur
Journal:  Case Rep Dent       Date:  2015-02-08

5.  In Vitro Effects of Cyclic Dislodgement on Retentive Properties of Various Titanium-Based Dental Implant Overdentures Attachment System.

Authors:  Tae-Yun Kang; Jee-Hwan Kim; Kwang-Mahn Kim; Jae-Sung Kwon
Journal:  Materials (Basel)       Date:  2019-11-16       Impact factor: 3.623

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.